Identifying the Barriers of Clinical Trial Access after CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma

被引：0
|
作者：
Kim, Kunhwa [1 ]
Ayers, Amy [2 ]
Ahmed, Sairah [2 ]
Claret, Linda [2 ]
Strati, Paolo [2 ]
Nair, Ranjit [2 ]
Nze, Chijioke [2 ]
Ramdial, Jeremy [3 ]
Torres, Janet [3 ]
Shpall, Elizabeth J. [3 ]
Fayad, Luis E. [4 ]
Nastoupil, Loretta [2 ]
Westin, Jason R. [2 ]
Flowers, Christopher R. [2 ]
Neelapu, Sattva S. [2 ]
Chihara, Dai [2 ]
机构：
[1] Univ Texas MD Anderson, Div Canc Med, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr Houston, Dept Lymphoma & Myeloma, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr Houston, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-211023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5121 / 5122
页数：2
相关论文
共 50 条
  • [1] CAR T-Cell Therapy for Relapsed/Refractory Aggressive Large B-Cell Lymphoma
    Gideon, Jacklyn
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2022, 26 (06) : 597 - 601
  • [2] Salvage Radiotherapy in Relapsed/ Refractory Large B-Cell Lymphoma After CAR T-Cell Therapy Failure
    Ababneh, Hazim
    Ng, Andrea
    Frigault, Matthew
    Abramson, Jeremy
    Johnson, Patrick
    Jacobson, Caron
    Patel, Chirayu
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S414 - S414
  • [3] Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapy
    Ababneh, Hazim S.
    Ng, Andrea K.
    Frigault, Matthew J.
    Abramson, Jeremy S.
    Johnson, Patrick Connor
    Jacobson, Caron A.
    Patel, C. G.
    HAEMATOLOGICA, 2023, 108 (11) : 2972 - 2981
  • [4] CAR T-cell therapy in refractory large B-cell lymphoma
    Stirrups, Robert
    LANCET ONCOLOGY, 2018, 19 (01): : E19 - E19
  • [5] Axicabtagene Ciloleucel: Clinical Data for the Use of CAR T-cell Therapy in Relapsed and Refractory Large B-cell Lymphoma
    Halford, Zachery
    Anderson, Mary Kate
    Bennett, Lunawati L.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (03) : 390 - 405
  • [6] Proton Therapy as a Bridging Treatment in CAR T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: Is There a Role?
    Saifi, Omran
    Kharfan-Dabaja, Mohamed A.
    Zeidan, Youssef H.
    Peterson, Jennifer
    Rule, William G.
    Lester, Scott C.
    Hoppe, Bradford S.
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2020, 7 (01) : 13 - 20
  • [7] Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma
    Vercellino, Laetitia
    Di Blasi, Roberta
    Kanoun, Salim
    Tessoulin, Benoit
    Rossi, Cedric
    D'Aveni-Piney, Maud
    Oberic, Lucie
    Bodet-Milin, Caroline
    Bories, Pierre
    Olivier, Pierre
    Lafon, Ingrid
    Berriolo-Riedinger, Alina
    Galli, Eugenio
    Bernard, Sophie
    Rubio, Marie-Therese
    Bossard, Celine
    Meignin, Veronique
    Merlet, Pascal
    Feugier, Pierre
    Le Gouill, Steven
    Ysebaert, Loic
    Casasnovas, Olivier
    Meignan, Michel
    Chevret, Sylvie
    Thieblemont, Catherine
    BLOOD ADVANCES, 2020, 4 (22) : 5607 - 5615
  • [8] Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
    Neelapu, S. S.
    Locke, F. L.
    Bartlett, N. L.
    Lekakis, L. J.
    Miklos, D. B.
    Jacobson, C. A.
    Braunschweig, I.
    Oluwole, O. O.
    Siddiqi, T.
    Lin, Y.
    Timmerman, J. M.
    Stiff, P. J.
    Friedberg, J. W.
    Flinn, I. W.
    Goy, A.
    Hill, B. T.
    Smith, M. R.
    Deol, A.
    Farooq, U.
    McSweeney, P.
    Munoz, J.
    Avivi, I.
    Castro, J. E.
    Westin, J. R.
    Chavez, J. C.
    Ghobadi, A.
    Komanduri, K. V.
    Levy, R.
    Jacobsen, E. D.
    Witzig, T. E.
    Reagan, P.
    Bot, A.
    Rossi, J.
    Navale, L.
    Jiang, Y.
    Aycock, J.
    Elias, M.
    Chang, D.
    Wiezorek, J.
    Go, W. Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26): : 2531 - 2544
  • [9] CAR T-Cell Therapy in Large B-Cell Lymphoma
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (11): : 1065 - 1065
  • [10] Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma
    Liu, Wei
    Zou, Hesong
    Chen, Lianting
    Huang, Wenyang
    Lv, Rui
    Xu, Yan
    Liu, Huimin
    Shi, Yin
    Wang, Kefei
    Wang, Yi
    Xiong, Wenjie
    Deng, Shuhui
    Yi, Shuhua
    Sui, Weiwei
    Peng, Guangxin
    Ma, Yueshen
    Wang, Huijun
    Lv, Lulu
    Wang, Jianxiang
    Wei, Jun
    Qiu, Lugui
    Zheng, Wenting
    Zou, Dehui
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
12345